,i #aaf? ,,congress #a/ ,session ,h4 ,r4 #dfbd ,,9 ,,! ,,h\se ,,( ,,repres5tatives ,octob] #h1 #bjai,mr4 ,kri%namoor?i introduc$ ! foll[+ bill2 :i* 0 ref]r$ to ! ,committee on ,en]gy & ,comm]ce ,a ,,bill ,to am5d ! ,f$]al ,food1 ,drug1 & ,cosmetic ,act to e/abli% a tobacco product /&>d prohibit+ any e-liquid ) a conc5tration ( nicot9e high] ?an #bj milligrams p] millilit]1 & = o!r purposes4 #a4 ,%ort title ,?is ,act may be cit$ z ! ,end+ ,nicot9e ,dep5d5ce f ,electronic ,nicot9e ,deliv]y ,sy/ems ,act ( #bjai or ! ,,end ,,ends ,act ( #bjai4 #b4 ,f9d+s ,congress f9ds z foll[s3 7#a7 ,accord+ to ! ,c5t]s = ,disease ,control & ,prev5tion 79 ?is section ref]r$ to z ! ,,cdc71 ! bra9 keeps develop+ until approximately age #be1 & nicot9e exposure c h>m ! p>ts ( ! bra9 t control att5tion1 le>n+1 mood1 & impulse control4 7#b7 ,adolesc5t nicot9e use may also increase ! risk ( future addiction to o!r drugs4 7#c7 ,a rec5t ,,cdc /udy f\nd t #ii p]c5t ( e-cig>ettes sold 9 ! ,unit$ ,/ates conta9 nicot9e4 7#d7 ,9 congressional te/imony be=e ! ,subcommittee on ,economic & ,consum] ,policy ( ! ,committee on ,ov]sight & ,re=m ( ! ,h\se ( ,repres5tatives on ,septemb] #bd1 #bjai1 ,,cdc ,pr9cipal ,deputy ,director ,anne ,s*u*at /at$ t f\r? g5]ation e-cig>ette devices 7 fir/ sold 9 #bjae & use nicot9e salts1 :i* c lead to mu* m available nicot9e4 7#e7 ,accord+ to ,dr4 ,s*u*at's te/imony1 f\r? g5]ation devices c cross ! blood-bra9 b>ri] & lead to pot5tially m effects on ! develop+ bra9 9 adolesc5ts4 ,fur!r1 ! v high levels ( accessible nicot9e & ! discreet use ( ! product directly l9k ! gr[+ popul>ity ( f\r? g5]ation e-cig>ette devices to ! rise 9 y\? e-cig>ette use4 7#f7 ,prior to ! use ( nicot9e salts1 :i* are n[ us$ 9 ! e-liquids ( ! mo/ popul> e-cig>ettes1 mo/ e-cig>ettes conta9$ freebase nicot9e4 ,because freebase nicot9e has a mu* h>%] effect on ! inhal]1 ^! e-cig>ette devices conta9$ mu* less nicot9e ?an devices :i* conta9 nicot9e salts4 7#g7 ,! mo/ popul> e-cig>ette manufactur$ & sold 9 ! ,unit$ ,/ates1 :i* is consid]$ a f\r? g5]ation device1 mo/ frequ5tly conta9s an e-liquid ) #ei milligrams p] millilit] ( nicot9e4 7#h7 ,9 response1 ! ,european ,union1 ! ,unit$ ,k+dom1 & ,israel implem5t$ regulations to cap ! conc5tration ( nicot9e 9 e-cig>ette e-liquids to #bj milligrams p] millilit]4 7#i7 ,! ,unit$ ,k+dom's nicot9e cap w5t into effect on ,may #bj1 #bjag4 ,z y\? use skyrocket$ 9 ! ,unit$ ,/ates betwe5 #bjag & #bjah1 ! p]c5tage ( y\? e-cig>ette us]s :o use m ?an once a week only rose f #a4b p]c5t to #a4g p]c5t1 & ! p]c5tage ( y\? :o use less ?an weekly decreas$ f #b4b p]c5t to #a4h p]c5t4 7#aj7 ,e-cig>ettes manufactur$ & sold 9 ! ,unit$ ,/ates are curr5tly n subject to any nicot9e cap1 & e-cig>ette manufactur]s are p]mitt$ to design _! products to be z addictive z possible4 7#aa7 ,accord+ to ! ,,cdc1 e-cig>ette use rose by #gh p]c5t among high s*ool]s & #dh p]c5t among middle s*ool]s betwe5 #bjag & #bjah4 7#ab7 ,prelim9>y results f ! ,,cdc's annual ,national ,y\? ,tobacco ,survey publi%$ 9 ,septemb] #bjai %[ t #bg4e p]c5t ( high s*ool /ud5ts report$ us+ an e-cig>ette 9 ! previ\s #cj days1 up f #bj4h p]c5t 9 #bjah4 7#ac7 ,! ,,cdc1 ! ,food & ,drug ,adm9i/ration1 ! ,dep>tm5t ( ,heal? & ,human ,s]vices1 ! ,surgeon ,g5]al ( ! ,public ,heal? ,s]vice1 & v>i\s ,/ate & local heal? au?orities h det]m9$ ! skyrocket+ e-cig>ette use among/ ,am]ican y\? to be an 8epidemic04 #c4 ,s5se ( ,congress ,x is ! s5se ( ! ,congress t-- 7#a7 effectively combat+ ! y\? e-cig>ette epidemic w require ! implem5tation ( bold & endur+ policy solutions2 7#b7 "u ! curr5t regulatory framework1 ,am]ican y\? h easy access to highly addictive f\r? g5]ation e-cig>ette devices t hook !m into a lifelong addiction to nicot9e2 7#c7 9 ord] to significantly decrease y\? e-cig>ette use & to r$uce ! dang]s associat$ ) excessive nicot9e inhalation1 ! ,f$]al ,gov]nm5t %\ld regulate nicot9e levels 9 e-cig>ettes 9 ord] to make !m less addictive & less h>mful to y\?2 & 7#d7 9 addition to regulat+ nicot9e levels1 ! ,f$]al ,gov]nm5t %\ld also review o!r factors relat$ to ! composition & function ( f\r? g5]ation e-cig>ettes 9 ord] to make !m less addictive & appeal+ to y\?1 includ+ batt]y p[] & design4 #d4 ,maximum nicot9e cont5t 9 e-liquids 7a7 ,tobacco product /&>d ,p>agraph 7#a7 ( section #ijg7;a7 ( ! ,f$]al ,food1 ,drug1 & ,cosmetic ,act 7#ba ,u4,s4,c4 #chg;g7a77 is am5d$ by add+ at ! end ! foll[+ new subp>agraph3 7,c7 ,nicot9e cont5t 9 e-liquids ,beg9n+ on ! date ( enactm5t ( ! ,end+ ,nicot9e ,dep5d5ce f ,electronic ,nicot9e ,deliv]y ,sy/ems ,act ( #bjai1 an e-liquid %all n h a conc5tration ( nicot9e high] ?an-- 7i7 #bj milligrams p] millilit]2 or 7ii7 su* l[] nicot9e conc5tration z is det]m9$ by ! ,secret>y to be m9imally addictive or non-addictive4 4 7b7 ,def9itions 7#a7 ,9 g5]al ,section #ijj ( ! ,f$]al ,food1 ,drug1 & ,cosmetic ,act 7#ba ,u4,s4,c4 #chg7 is am5d$-- 7,a7 by r$esignat+ p>agraphs 7#h7 ?r\gh 7#bb7 z p>agraphs 7#aj7 ?r\gh 7#bd71 respectively2 & 7,b7 by ins]t+ aft] p>agraph 7#g7 ! foll[+3 7#h7 ,electronic nicot9e deliv]y sy/em ,! t]m electronic nicot9e deliv]y sy/em means a tobacco product t is an electronic device t deliv]s nicot9e1 flavor1 or ano!r sub/ance via an a]osoliz$ solution to ! us] inhal+ f ! device 7includ+ e-cig>ettes1 e-hookah1 e-cig>s1 vape p5s1 advanc$ refillable p]sonal vaporiz]s1 & electronic pipes7 & any compon5t1 liquid1 "p1 or accessory ( su* a device1 :e!r or n sold sep>ately4 7#i7 ,e-liquid ,! t]m e-liquid means any liquid int5d$ = use ) an electronic nicot9e deliv]y sy/em4 4 7#b7 ,con=m+ am5dm5t ,section #i7a7 ( ! ,compreh5sive ,smokeless ,tobacco ,heal? ,education ,act ( #aihf 7#ae ,u4,s4,c4 #ddjh7a77 is am5d$ by /rik+ #ijj7ah7 & ins]t+ #ijj7bj74